In vivo evaluation and dosimetry of 123I-2-iodo-D-phenylalanine, a new potential tumor-specific tracer for SPECT, in an R1M rhabdomyosarcoma athymic mouse model.
UNLABELLED: Earlier reports described the preferential uptake of d-amino acids in tumor-bearing mice. Moreover, it was shown that in tumor cells in vitro the L-amino acid transporter system seemed to lack stereospecificity. Because of the successful results with 123/125I-2-iodo-L-phenylalanine, 123...
Main Authors: | Kersemans, V, Cornelissen, B, Bacher, K, Kersemans, K, Thierens, H, Dierckx, R, De Spiegeleer, B, Slegers, G, Mertens, J |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2005
|
Similar Items
-
In vivo characterization of 123/125I-2-iodo-L-phenylalanine in an R1M rhabdomyosarcoma athymic mouse model as a potential tumor tracer for SPECT.
by: Kersemans, V, et al.
Published: (2005) -
In vivo characterization of [123I]-2-Iodo-L-Phenylalanine in growing R1M rabdomyosarcoma bearing athymic mice as a potential tumour tracer for SPECT
by: Kersemans, V, et al.
Published: (2004) -
Comparative biodistribution study of the new tumor tracer [123I]-2-iodo-L-phenylalanine with [123I]-2-iodo-L-tyrosine.
by: Kersemans, V, et al.
Published: (2006) -
In vivo evaluation of [I-123]-2-Iodo-D-Phenylalanine in tumour inoculated athymic mice by means of SPECT as a potential diagnostic and radionuclide therapy tool.
by: Kersemans, V, et al.
Published: (2004) -
Detection of various tumour types in athymic mice with [123I]-2-Iodo-L-Phenylalanine and planar gamma camera acquisition
by: Kersemans, V, et al.
Published: (2004)